PB
Pinal Bhargav Kaswala
About Pinal Bhargav Kaswala
Data last updated:
Pinal Bhargav Kaswala has 3 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Medvac Pharma Private Limited and Avento Surgicals Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Medvac Pharma Private Limited at ₹1.11 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Nov 2022 | 2022 | ₹1.11 Cr (FY 2025) | Active | |
| Designated Partner | 08 Jul 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pinal Bhargav Kaswala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pinal Bhargav Kaswala
Pinal Bhargav Kaswala has 3 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Medvac Pharma Private Limited and Avento Surgicals Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Medvac Pharma Private Limited at ₹1.11 Cr (FY 2025).
Pinal Bhargav Kaswala is associated with 2 companies as Director and Designated Partner, including Medvac Pharma Private Limited (₹1.11 Cr), Avento Surgicals Llp.
Pinal Bhargav Kaswala has expertise in General Business.
Pinal Bhargav Kaswala has 3 years in corporate governance.
By reported revenue, the largest current company of Pinal Bhargav Kaswala is Medvac Pharma Private Limited, with revenue of ₹1.11 Cr (FY 2025).
Pinal Bhargav Kaswala currently holds positions at 2 companies: Medvac Pharma Private Limited (₹1.11 Cr), Avento Surgicals Llp.